G-CSF, M-CSF, and GM-CSF have been employed in the management of invasive fungal infections stemming from Candida (61, 62) and Aspergillus (63–66), especially in patients undergoing chemotherapy or after stem cell transplantation (67–69). The gene discussed is CSF2; the disease is fungal infectious disease.